News Archive

Join us this month at a special Baltimore BioBuzz to to showcase the region’s #1 ranked strength among other Biotech industry hubs – our talent. Graduate Student groups from JHU and UMB have come together to sponsor BioBuzz and welcome all of our regional industry partners to join them. They are all seeking to connect with and impact our regional industry and ecosystem and begin to show you what their vision of tomorrow looks like.

Come out on May 26th to the Baltimore BioBuzz at Heavy Seas Ale House to meet the leaders, innovators and entrepreneurs of tomorrow.

Event is for Post-Docs & Professional Scientists currently working in the Therapeutic Areas of:

•Oncology

•Respiratory, Inflammation & Autoimmunity

•Cardiovascular & Metabolic Diseases

•Infectious Diseases & Vaccines

•Related scientific disciplines    

Event will include music, lawn games, hors d’oeuvres, drinks.

Helping individuals returning from incarceration pay for housing, mentoring high school students to build robotic cars, and providing a system to reuse dorm furnishings and supplies are among the winning ideas to emerge from the latest round of online crowdsourcing on the Johns Hopkins Idea Lab.

IBM today announced a multi-year, cognitive computing collaboration with the University of Maryland in Baltimore on an Accelerated Cognitive Cybersecurity Laboratory (ACCL). It’s the second such move in a month. In mid-April Big Blue announced plans for the Center for Cognitive Computing Systems Research (C3SR) to be based at the University of Illinois Urbana-Champaign.

Hong-Kong based Value Measured Investment Limited led a $10 million Series B financing in Sirnaomics, Inc., a biopharmaceutical company focusing on RNAi therapeutics. The funding will go towards development of anti-fibrosis treatments, with a Phase I clinical trial planned for early second half of 2016.

GenVec, Inc. (NasdaqCM: GNVC) (“GenVec” or “the Company”), today announced that it has entered into a definitive agreement with institutional investors for an offering of shares of common stock with gross proceeds of approximately $5 million in an at-the-market registered direct offering. The closing of the offering is expected to take place on or about May 10, 2016, subject to the satisfaction of customary closing conditions.

Johns Hopkins University President Ronald J. Daniels was among the panelists at the Milken Institute’s Global Conference last week, taking part in a discussion on how universities across the country are increasing their roles in regional economic development.

The panelists examined innovative models of collaboration with the private and government sectors that are spurring regional economic growth. They also discussed how universities are walking the tightrope of balancing a commitment to basic scientific research—where new knowledge is generated—with their desire and need to maximize returns from transferring technology to the private sector.

Kevin Haley doesn’t pay attention to the competition. As president of product and innovation for Under Armour, he encourages his team to ignore the noise and focus on their own game.

Kathy Snyder can go back to the beach now.

Snyder came out of retirement last year to once again take over the Maryland Chamber of Commerce when its CEO unexpectedly resigned. On Tuesday, the Chamber announced Snyder’s replacement, Christine Ross, currently the CEO of the Bonita Springs Area Chamber of Commerce in Florida, will take over the organization on July 11.

After six years of existence and raising more than $20 million, Personal Genome Diagnostics has its first full-time CEO.

Douglas Ward will head the Canton-based Johns Hopkins spinout and sit on its board, the company announced Monday.